Literature DB >> 26294291

Inflammation and the bone-vascular axis in end-stage renal disease.

L Viaene1, G J Behets2, S Heye3, K Claes1, D Monbaliu4, J Pirenne4, P C D'Haese2, P Evenepoel5,6.   

Abstract

UNLABELLED: Bone loss and vascular calcification coincide in patients with end-stage renal disease, similar as to what is observed in the general population. In the present bone biopsy study, we provide further evidence that (micro-)inflammation may represent a common soil for both diseases.
INTRODUCTION: Vascular calcification is a common complication of end-stage renal disease (ESRD) and is predictive of subsequent cardiovascular disease and mortality. Mounting evidence linking bone disorders with vascular calcification has contributed to the development of the concept of the bone-vascular axis. Inflammation is involved in the pathogenesis of both disorders. The aim of the present study was to evaluate the relationship between aortic calcification, inflammation, and bone histomorphometry in patients with ESRD.
METHODS: Parameters of inflammation and mineral metabolism were assessed in 81 ESRD patients (55 ± 13 year, 68 % male) referred for renal transplantation. Static bone histomorphometry parameters were determined on transiliac bone biopsies performed during the transplant procedure. Aortic calcification was quantified on lateral lumbar X-rays using the Kauppila method.
RESULTS: Aortic calcification, low bone turnover, and low bone area were observed in 53, 37, and 21 % of patients respectively. Inflammatory markers were found to be independently associated with aortic calcification (hsIL-6) and low bone area (TNF-α). Low bone area associated with aortic calcification, independent of age, diabetes, and inflammation.
CONCLUSIONS: Low bone area and inflammation associates with aortic calcification, independent of each other and traditional risk factors. Our data emphasize the role of (micro-)inflammation in the bone-vascular axis in CKD.

Entities:  

Keywords:  Aortic calcification; Bone histomorphometry; End-stage renal disease

Mesh:

Substances:

Year:  2015        PMID: 26294291     DOI: 10.1007/s00198-015-3233-8

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  52 in total

Review 1.  Osteoporosis in chronic kidney disease.

Authors:  John Cunningham; Stuart M Sprague; Jorge Cannata-Andia; Maria Coco; Martine Cohen-Solal; Lorraine Fitzpatrick; David Goltzmann; Marie-Helene Lafage-Proust; Mary Leonard; Susan Ott; Mariano Rodriguez; Catherine Stehman-Breen; Paula Stern; Jose Weisinger
Journal:  Am J Kidney Dis       Date:  2004-03       Impact factor: 8.860

2.  High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease.

Authors:  Vidya M Raj Krishnamurthy; Guo Wei; Bradley C Baird; Maureen Murtaugh; Michel B Chonchol; Kalani L Raphael; Tom Greene; Srinivasan Beddhu
Journal:  Kidney Int       Date:  2011-10-19       Impact factor: 10.612

Review 3.  Arterial calcification and bone physiology: role of the bone-vascular axis.

Authors:  Bithika Thompson; Dwight A Towler
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

4.  Monocyte/macrophage regulation of vascular calcification in vitro.

Authors:  Yin Tintut; Jignesh Patel; Mary Territo; Trishal Saini; Farhad Parhami; Linda L Demer
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

Review 5.  Cell biological and physicochemical aspects of arterial calcification.

Authors:  Ellen Neven; Tineke M De Schutter; Marc E De Broe; Patrick C D'Haese
Journal:  Kidney Int       Date:  2011-03-16       Impact factor: 10.612

6.  Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study.

Authors:  Matthew J Budoff; Daniel J Rader; Muredach P Reilly; Emile R Mohler; Jim Lash; Wei Yang; Leigh Rosen; Melanie Glenn; Valerie Teal; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2011-07-23       Impact factor: 8.860

7.  Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.

Authors:  Markus Ketteler; Philipp Bongartz; Ralf Westenfeld; Joachim Ernst Wildberger; Andreas Horst Mahnken; Roland Böhm; Thomas Metzger; Christoph Wanner; Willi Jahnen-Dechent; Jürgen Floege
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

8.  Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation.

Authors:  Jesper Hjortnaes; Jonathan Butcher; Jose-Luiz Figueiredo; Mark Riccio; Rainer H Kohler; Kenneth M Kozloff; Ralph Weissleder; Elena Aikawa
Journal:  Eur Heart J       Date:  2010-07-02       Impact factor: 29.983

9.  Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study.

Authors:  Joseph A Hyder; Matthew A Allison; Nathan Wong; Agnes Papa; Thomas F Lang; Claude Sirlin; Susan M Gapstur; Pamela Ouyang; J Jeffrey Carr; Michael H Criqui
Journal:  Am J Epidemiol       Date:  2008-12-08       Impact factor: 4.897

10.  Prospective association between inflammatory markers and progression of coronary artery calcification in adults with and without type 1 diabetes.

Authors:  Amy C Alman; Gregory L Kinney; Russell P Tracy; David M Maahs; John E Hokanson; Marian J Rewers; Janet K Snell-Bergeon
Journal:  Diabetes Care       Date:  2013-01-22       Impact factor: 19.112

View more
  15 in total

Review 1.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

Review 2.  CKD-MBD: from the Pathogenesis to the Identification and Development of Potential Novel Therapeutic Targets.

Authors:  Rosilene Motta Elias; Maria Aparecida Dalboni; Ana Carolina E Coelho; Rosa M A Moysés
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

Review 3.  Traditional and Non-traditional Risk Factors for Osteoporosis in CKD.

Authors:  Hanne Skou Jørgensen; Karel David; Syazrah Salam; Pieter Evenepoel
Journal:  Calcif Tissue Int       Date:  2021-02-14       Impact factor: 4.333

4.  Systemic Profile of Cytokines in Arteriovenous Fistula Patients and Their Associations with Maturation Failure.

Authors:  Laisel Martinez; Mikael Perla; Marwan Tabbara; Juan C Duque; Miguel G Rojas; Nieves Santos Falcon; Simone Pereira-Simon; Loay H Salman; Roberto I Vazquez-Padron
Journal:  Kidney360       Date:  2022-01-13

5.  Activation of the mTORC1 pathway by inflammation contributes to vascular calcification in patients with end-stage renal disease.

Authors:  Jing Liu; Wei Zhu; Chun Ming Jiang; Yuan Feng; Yang Yang Xia; Qing Yan Zhang; Miao Zhang
Journal:  J Nephrol       Date:  2018-05-14       Impact factor: 3.902

6.  Safety of Low-calcium Dialysate and its Effects on Coronary Artery Calcification in Patients Undergoing Maintenance Hemodialysis.

Authors:  Yang Wen; Hua Gan; Zhengrong Li; Ximin Sun; Ying Xiong; Yunfeng Xia
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

Review 7.  The Role of Gut Dysbiosis in the Bone-Vascular Axis in Chronic Kidney Disease.

Authors:  Pieter Evenepoel; Sander Dejongh; Kristin Verbeke; Bjorn Meijers
Journal:  Toxins (Basel)       Date:  2020-04-29       Impact factor: 4.546

Review 8.  Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease.

Authors:  Mathias Haarhaus; Dean Gilham; Ewelina Kulikowski; Per Magnusson; Kamyar Kalantar-Zadeh
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-01       Impact factor: 3.416

9.  Shuxuetong injection simultaneously ameliorates dexamethasone-driven vascular calcification and osteoporosis.

Authors:  Zhe Xu; Xiaoguang Liu; Yanqing Li; Hongliang Gao; Tao He; Chunlei Zhang; Wei Hao; Xu Teng
Journal:  Exp Ther Med       Date:  2021-01-08       Impact factor: 2.447

10.  Tumor necrosis factor-alpha is associated with mineral bone disorder and growth impairment in children with chronic kidney disease.

Authors:  Kelly Meza; Sharmi Biswas; Yuan-Shan Zhu; Anuradha Gajjar; Eduardo Perelstein; Juhi Kumar; Oleh Akchurin
Journal:  Pediatr Nephrol       Date:  2021-01-02       Impact factor: 3.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.